Literature DB >> 26311727

Does molecular monitoring matter in early-stage breast cancer?

Tilak K Sundaresan1, Daniel A Haber2.   

Abstract

Serial monitoring of circulating tumor DNA predicts recurrence after treatment for localized breast cancer (Garcia-Murillas et al., this issue).
Copyright © 2015, American Association for the Advancement of Science.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26311727     DOI： 10.1126/scitranslmed.aac9445

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN： 1946-6234            Impact factor:   17.956


  2 in total

Review 1.  Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.

Authors:  Xiaofen Zhang; Shaoqing Ju; Xudong Wang; Hui Cong
Journal:  Clin Exp Med       Date:  2019-06-12       Impact factor: 3.984

2.  The Potential Use of Dynamics Changes of ctDNA and cfDNA in the Perioperative Period to Predict the Recurrence Risk in Early NSCLC.

Authors:  Xiaolong Zhao; Fuqiang Dai; Longyong Mei; Depei Huang; Xudong Shen; Hushan Zhang; Xueke She; Zheng Ma
Journal:  Front Oncol       Date:  2021-07-16       Impact factor: 6.244
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.